People with multiple sclerosis living in England say they're victims of medical apartheid

The video discusses the challenges faced by MS patients in England due to the limited availability of a drug called Sativex, which is restricted by the NHS due to cost concerns. Jackie Langham, an MS patient, highlights the postcode lottery in health care, while NHS Wales has approved funding for the drug. Tony Wiggins, who participated in a trial, supports its effectiveness. NICE has not recommended Sativex, citing cost-effectiveness issues. The hope for English MS patients lies in new evidence that could alter NICE's stance before final recommendations are published.

What new insight or understanding did you gain from this video?